CLINICAL_TRIALS
trial_result
· 2022-09-01
Clinical Trial Update: Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202) [Phase 2]
Summary
Phase 2 trial evaluating SDP-4 for dry eye disease has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Silk Technologies, Ltd. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2022-09-01